These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23431223)

  • 1. Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.
    Filak LK; Göschl S; Heffeter P; Ghannadzadeh Samper K; Egger AE; Jakupec MA; Keppler BK; Berger W; Arion VB
    Organometallics; 2013 Feb; 32(3):903-914. PubMed ID: 23431223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.
    Filak LK; Mühlgassner G; Bacher F; Roller A; Galanski M; Jakupec MA; Keppler BK; Arion VB
    Organometallics; 2011 Jan; 30(2):273-283. PubMed ID: 21253447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.
    Filak LK; Kalinowski DS; Bauer TJ; Richardson DR; Arion VB
    Inorg Chem; 2014 Jul; 53(13):6934-43. PubMed ID: 24927493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-
    Filak LK; Göschl S; Hackl S; Jakupec MA; Arion VB
    Inorganica Chim Acta; 2012 Dec; 393(7):252-260. PubMed ID: 23471093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
    Filak LK; Mühlgassner G; Jakupec MA; Heffeter P; Berger W; Arion VB; Keppler BK
    J Biol Inorg Chem; 2010 Aug; 15(6):903-18. PubMed ID: 20369265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
    Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
    Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.
    Grguric-Sipka S; Stepanenko IN; Lazic JM; Bartel C; Jakupec MA; Arion VB; Keppler BK
    Dalton Trans; 2009 May; (17):3334-9. PubMed ID: 19421637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.
    Ginzinger W; Mühlgassner G; Arion VB; Jakupec MA; Roller A; Galanski MS; Reithofer M; Berger W; Keppler BK
    J Med Chem; 2012 Apr; 55(7):3398-413. PubMed ID: 22417128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
    Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
    J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Arion VB
    Inorg Chem; 2011 Aug; 50(16):7690-7. PubMed ID: 21739939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homo- and Hetero-dinuclear Arene-Linked Osmium(II) and Ruthenium(II) Organometallics: Probing the Impact of Metal Variation on Reactivity and Biological Activity.
    Wilson CS; Prior TJ; Sandland J; Savoie H; Boyle RW; Murray BS
    Chemistry; 2020 Sep; 26(50):11593-11603. PubMed ID: 32520396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
    Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
    Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BODIPY-based Ru(II) and Ir(III) organometallic complexes of avobenzone, a sunscreen material: Potent anticancer agents.
    Gupta G; Cherukommu S; Srinivas G; Lee SW; Mun SH; Jung J; Nagesh N; Lee CY
    J Inorg Biochem; 2018 Dec; 189():17-29. PubMed ID: 30153544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
    Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
    Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
    Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
    Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
    Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Os(IV)Cl(5)(Hazole)](-) complexes: synthesis, structure, spectroscopic properties, and antiproliferative activity.
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Arion VB; Keppler BK
    Inorg Chem; 2009 Nov; 48(22):10737-47. PubMed ID: 19842663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.